|
Behind
the Smokescreen
As anti-smoking campaigns become more visible, the market
for nicotine replacement therapies will also pick up. Suja
Nair explores
Actis
Biologics completes two acquisitions in US
Actis Biologics has acquired patented techn-ology platform
for effective treatment of hepatic cancer, from CellPoint
Diagnostics, USA, which is based on ligand linker drug delivery
[LLD] system, and can trem-endously reduce the toxicity of
chemotherapeutic agents
'Rural
areas account for 21 percent to the country's pharma market'
Himalaya Drug Company's entry in to rural markets is strategic
and they plan to generate between 10-15 percent of its existing
turnover through this division. Philipe Haydon, President
and CEO, Pharmaceuticals, Asia-Pacific, The Himalaya Drug
Company, shares more details in conversation with Arshiya
Khan
DRL
inks pact with Cosmederm Technologies
Dr Reddy's Laboratories (DRL) has entered into a licensing
and distribution agreement with Cosmederm Technologies (CT),
a US-based specialty pharmaceutical company focused on dermatology
and aesthetic medicine
Sun
Pharma wins case against Taro
Sun Pharmaceutical won a case in Israel which was filed against
by Taro regarding an open offer for the latter.
Marksans
Pharma acquires Relonchem
Marksans Pharmaceutical has acquired UK-based generic pharmaceutical
company Relonchem for an undisclosed amount. The deal will
be funded through internal accruals and part of it will be
through loan from banks
DCGI
to unveil CDSCO's Vision 2020 at 60th IPC
The 60th Indian Pharmaceutical Congress (IPC), scheduled for
December this year in Delhi, is slated to be a key platform
for national regulatory authorities to unveil a regulatory
roadmap
French
companies to exhibit at INDIA CHEM 2008
India Chem 2008, is due to have a sizable business delegation
from France as part of the French Pavilion by a collaborative
effort of Ubifrance and the India Trade Missions
ISCR
institutes awards in clinical research
During the last few years India has emerged as one of the
most preferred destinations to conduct clinical studies in
Asia
InformEx-2009
to be held in Ahmedabad
After 25 years of enhancing the pharmaceutical and chemical
industry in the US, InformexUSA will hold its first India
edition in March next year
Event
Brief
India
to become global Ayurveda leader
The International Grand Centennial Convention (IGCC) and Arogya
Ayurveda Expo 2008 was conducted at Codissia trade fair complex,
Coimbatore from 21-24 August, 2008
Rubicon
inaugurates the first CTS facility in India
Rubicon Research, a product development and drug delivery
company, held a seminar on 'Clinical trial supplies-Challenges
and opportunities' to mark the inauguration of its cGMP Clinical
Trial Supplies (CTS) facility at Ambernath (50 kms from Mumbai
international airport) on August 19,2008
|
